Lysosomal Profiling With LysoTracker For Quantitative Assessment of Cellular Senescence In Human Fibroblasts
July 17th, 2026
This article presents a live-cell LysoTracker protocol to measure lysosomal remodeling during senescence in IMR-90 human fibroblasts.
We study cellular senescence and its characterization, focusing on how features like lysosomal changes can serve as senescence markers. Conventional senescence markers are often endpoint-based and binary, while live-cell imaging can read senescence as a continuous quantitative signal across conditions. To begin, seed IMR-90 fibroblasts in a 24-well plate and incubate them at 37 degrees Celsius in a 5%carbon dioxide incubator until they form a subconfluent monolayer.
Record the seeding density and the time between plating and lysosomal staining for each experiment. Warm the complete culture medium to 37 degrees Celsius. Prepare a 75 nanomolar LysoTracker Deep Red working solution in the medium, and protect it from light.
Mix the working solution by gentle inversion. Select matched pre-senescent and senescent IMR-90 fibroblast cohorts prepared using a defined senescence induction method. Confirm the senescent phenotype by monitoring growth characteristics and morphology.
Aspirate the spent medium from each well. Gently add the LysoTracker working solution along the wall of each well, avoiding disturbance to the monolayer. Incubate the cells with LysoTracker for 30 minutes at 37 degrees Celsius in a 5%carbon dioxide incubator.
During the final 10 minutes of LysoTracker incubation, add Hoechst 33342 directly to the wells at the manufacturer recommended working concentration and mix by gently rocking the plate. Remove the staining medium at the end of the incubation and rinse the cells once with pre-warmed PBS to reduce background fluorescence. Immediately after the rinse, add pre-warmed phenol red-free culture medium.
Proceed directly to live cell imaging, keeping the time from buffer exchange to data acquisition consistent across all wells. Label the parallel wells in the culture plate for beta-galactosidase staining to compare highly senescent cells with the pre-senescent controls. Complete live-cell imaging for the validation wells before fixation.
Record the stage coordinates during live imaging to relocate the same fields after fixation. Add the fixation solution from the senescence beta-galactosidase staining kit containing 2%formaldehyde and 0.2%glutaraldehyde to the cells. Cover the plate with the lid and incubate for 10 to 15 minutes at room temperature.
Remove the fixative and rinse the wells twice with PBS. Then add the beta-galactosidase staining solution containing the X-gal substrate at pH 6 to each well. Seal the plate with parafilm to limit evaporation during incubation, and place the plate in a 37 degrees Celsius dry incubator without carbon dioxide for 12 to 16 hours.
After fixation and staining, place the plate on the microscope stage and relocate the same imaging fields using the recorded stage coordinates. Inspect the wells under a brightfield microscope and document the staining pattern. Acquire representative images for each condition and determine the fraction of senescence-associated beta-galactosidase positive cells per well.
Senescent cells showed bright, spatially expanded paranuclear lysosome-enriched regions, whereas pre-senescent controls showed lower overall signal with discrete punctate structures. Senescent conditions showed a higher fraction of beta-gal positive cells than pre-senescent controls. A strong correlation was observed between LysoTracker intensity and senescence-associated beta-gal positive area across the replicate wells.
The mean LysoTracker intensity within the positive mask was higher in senescent cultures than in pre-senescent cultures, making it the most robust field-level discriminator between the two conditions. The integrated LysoTracker intensity per nucleus was also higher in senescent cultures in the representative field shown. This protocol enables researchers to measure lysosomal remodeling in living cells, providing a quantifiable single-cell readout of senescence burden and progression.
It is important to keep the staining and imaging settings identical across all wells, since intensity comparisons are only valid within one session. Future studies can extend this procedure to three-dimensional models, additional cell types, and validation across different microscope systems and workflows.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a live-cell imaging protocol for assessing cellular senescence by quantifying lysosomal remodeling using LysoTracker Deep Red, an acidotropic fluorescent dye. The method provides an indirect, pH-dependent readout of the acidic organelle compartment, serving as a practical correlate of senescence burden in cultured cells, specifically demonstrated in IMR-90 human lung fibroblasts undergoing replicative senescence.
Key Study Components
Area of Science
- Cellular senescence
- Cell biology
- Live-cell imaging
Background
- Cellular senescence is characterized by stable cell-cycle arrest and distinct phenotypes, including enlarged morphology and altered secretory profiles.
- Senescent cells show pronounced lysosomal remodeling and expansion of the acidic endo-lysosomal compartment.
- Changes in lysosomal acidity and degradative capacity are hallmarks of senescence.
- Traditional senescence assays include SA-β-Gal staining, but live-cell compatible, quantitative methods are needed.
Purpose of Study
- To provide a simple, live-cell imaging protocol for quantifying lysosomal remodeling as a correlate of senescence.
- To demonstrate the use of LysoTracker Deep Red for assessing acidic organelle expansion in senescent cells.
- To offer a quantitative complement to conventional endpoint assays for senescence.
Methods Used
- Culturing and serial passaging of IMR-90 human lung fibroblasts to induce replicative senescence.
- Staining live cells with LysoTracker Deep Red to label acidic organelles.
- Fluorescence imaging to visualize and quantify lysosomal signal intensity and lyso-positive area per cell.
- Optional SA-β-Gal staining on parallel cultures as a confirmatory marker.
Main Results
- Late-passage, senescent cultures exhibited higher LysoTracker signal and larger lyso-positive regions compared to early-passage controls.
- The observed increase in acidotropic dye signal is consistent with expansion of the acidic organelle compartment during senescence.
- The method provides an indirect, quantitative measure of lysosomal remodeling associated with senescence.
Conclusions
- The protocol offers a simple, adaptable approach for live-cell assessment of senescence-linked lysosomal remodeling.
- Results should be interpreted as indirect correlates of lysosomal changes, not direct measures of lysosome number or biogenesis.
- The method can be extended to other cell types or senescence-inducing conditions.
Frequently Asked Questions
Executive Industry Relevance
Quantitative assessment of cellular senescence using LysoTracker-based lysosomal profiling enables early detection of senescence-linked organelle remodeling in human fibroblasts. This live-cell imaging approach provides a scalable, indirect readout of senescence burden, supporting predictive confidence in discovery-stage cell models. Integrating such quantitative, adaptable assays strengthens portfolio triage and mechanistic de-risking in preclinical research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of senescence-associated organelle remodeling as a functional biomarker.
- Supports biological de-risking by quantifying lysosomal changes linked to cell-cycle arrest.
- Facilitates predictive confidence in cell-based models for target validation.
Screening & Assay Development
- Prepares validated, live-cell systems for downstream screening of senescence-modulating compounds.
- Delivers quantitative, reproducible readouts of lysosomal signal intensity and area per cell.
- Enables assay standardization and scalability for high-content screening platforms.
Translational & Preclinical Research
- Aligns with disease-relevant modeling of senescence in human fibroblasts.
- Provides continuity from discovery through preclinical validation of senescence-modifying interventions.
- Supports risk-adjusted advancement decisions by quantifying cellular remodeling endpoints.
Pipeline & Workflow Integration
This lysosomal profiling protocol fits within the early discovery to preclinical continuum, enabling hypothesis testing and quantitative assessment of senescence in cell models.
- Discovery Biology: Supports hypothesis testing of senescence-linked lysosomal remodeling and pathway clarification.
- Screening: Provides reproducible, quantitative outputs for compound evaluation in live-cell assays.
- Analytics: Delivers image-based measurements of lysosomal signal intensity and area per cell for comparative analysis.
- Translational Research: Maintains continuity with disease-relevant fibroblast models and senescence endpoints.
- Enterprise Reuse: Offers a broadly adaptable, live-cell assay platform for diverse senescence-inducing conditions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in senescence studies.
- Operational Value: Enables standardization, reproducibility, and scalability in live-cell imaging workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing quantitative, early-stage readouts.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of senescence-modifying candidates.
Implementation Considerations
- Requires expertise in live-cell imaging and quantitative image analysis.
- Needs access to fluorescence microscopy and compatible analytical software.
- Demands cross-team standardization of staining and imaging protocols.
- Adaptable to various cell types and senescence-inducing stresses with protocol optimization.
- Interpretation is limited to indirect correlates of lysosomal remodeling, not direct lysosome quantification.
